Agios Pharmaceuticals Inc. (AGIO) News Nov 20, 2014, 5:35

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 7:00 PM

Agios Pharmaceuticals Inc. (AGIO) News Nov 20, 2014, 5:35 p.m.
MarketWatch News on AGIO
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
S&P 500 returns to scene of the breakdown 9:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 10:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 8:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 6:28 a.m. April 7, 2014 - Sara Sjolin

Other News on AGIO
Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog 4:33 p.m. Today - Zacks.com
Agios Pharmaceuticals (AGIO) Showing Signs Of Perilous Reversal Today 9:48 a.m. Today - TheStreet.com
Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO) 2:11 p.m. Nov. 19, 2014 - TheStreet.com
Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher' 11:21 a.m. Nov. 19, 2014 - TheStreet.com
Agios leukemia drug candidate shows clinical activity in Phase 1 trial 9:01 a.m. Nov. 19, 2014 - Seeking Alpha
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's Post-Market Leader Stock 6:20 p.m. Nov. 18, 2014 - TheStreet.com
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells 6:02 p.m. Nov. 18, 2014 - TheStreet.com
Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment 2:20 p.m. Nov. 12, 2014 - TheStreet.com
11 Biotechnology Stocks to Buy Now 4:15 a.m. Nov. 12, 2014 - InvestorPlace.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript 7:31 a.m. Nov. 8, 2014 - Seeking Alpha
Agios Pharmaceuticals (AGIO) Stock: Weak On High Volume Today 10:02 a.m. Nov. 7, 2014 - TheStreet.com
Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog 5:10 p.m. Nov. 6, 2014 - Zacks.com
Insider Trading Alert - ENTA, CTSH And AGIO Traded By Insiders 11:24 a.m. Nov. 5, 2014 - TheStreet.com
Super Important Biotech and Drug Stock Events for November 8:24 a.m. Nov. 3, 2014 - TheStreet.com
Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14) 6:59 a.m. Oct. 29, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals 6:00 a.m. Oct. 29, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Winners in the Expectations Game 8:26 p.m. Oct. 28, 2014 - TheStreet.com
Fab Four - Got To Get You Into My Life 1:24 p.m. Oct. 24, 2014 - Seeking Alpha

Press Releases on AGIO
Critical Alerts For Agios Pharmaceuticals, Target, Dollar General, Lululemon and Costco Released By InvestorsObserver 9:31 a.m. Today - PR Newswire - PRF
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML) 6:01 p.m. Nov. 18, 2014 - GlobeNewswire
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 7, 2014 - GlobeNewswire
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting 9:09 a.m. Nov. 6, 2014 - GlobeNewswire
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014 7:32 a.m. Oct. 27, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation 7:31 a.m. Oct. 21, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221 6:30 a.m. Oct. 15, 2014 - GlobeNewswire
Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014 8:02 a.m. Oct. 6, 2014 - GlobeNewswire
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 7:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Critical Alerts For Invensense, Agios Pharmaceuticals, SPDR Gold Trust, Nu Skin Enterprises and Nike Released By InvestorsObserver 8:31 a.m. Sept. 29, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014 6:30 a.m. Sept. 26, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable 3:06 p.m. Sept. 23, 2014 - GlobeNewswire
Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner 8:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation 7:30 a.m. Aug. 13, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 12:38 p.m. Aug. 12, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results 6:31 a.m. Aug. 7, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 10:14 a.m. July 31, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014 8:01 a.m. July 28, 2014 - GlobeNewswire
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 7:30 a.m. July 23, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Coastal Financial Faces $470M Wipeout: Investor Alert

Revelations Hit Coastal Financial Hard Alright, pull up a chair and let’s chew over what just happened with Coastal Financial Corporation (NASDAQ: CCB). This is the sort of deal that makes seasoned investors shake their heads in disbelief. Between October 28, 2024, and July 29, 2026, anyone buying into Coastal was buying into a mess they didn’t sign up for. We're...

Asset Based Lending's $200M Securitization: A Power Move

Well, folks, Asset Based Lending (ABL) in Jersey City just pulled a rabbit out of a challenging market hat, hammering out their heftiest securitization yet—a crisp $200 million deal. This isn't just pocket change, even for a seasoned player like ABL. Let's dive into what makes this move not just hefty in size, but a strategic punch in the current landscape of...

Flor de Caña's Green Strategy Wins 2026 Stevie Award

Flor de Caña’s Environmental Triumph Seems like when folks think of premium rum, they might wanna start picturing not just smooth sips but a green commitment that runs deep. Flor de Caña has bagged a Stevie Award for their solid 'Net Zero Strategy of the Year.' This ain’t just any award; it's a nod from a respected crowd. A handshake from the business big shots who...

Toronto's Distillery Winter Village Kicks Off 2026

Toronto's Holiday Spirit Ignites Toronto just cranked up the holiday spirit with the lighting of a 55-foot Christmas tree at The Distillery Winter Village. Let me tell you, it's a sight that could warm your innards on the coldest winter night. Presented by Quince, this winter wonderland opened its doors for 2026—and it's looking like they're pulling out all the stops...

Parallels Desktop: Top Dog for Windows on Mac

A Simpler Way to Bridge the Mac and Windows World Seems like Parallels Desktop is once again flexing its muscles for Mac users in 2026. Expert Consumers out of New York just gave them the thumbs-up as the go-to pick for folks wanting to hitch their Mac wagon to Windows 11. And why not? Parallels lets you take a stroll through Windows land without cutting your Mac ties. A...

Arbor Realty’s Legal Scramble: Hard Truths for NYSE:ABR

Reality Hits Arbor Realty Hard Well, isn't it a tangled mess over at Arbor Realty Trust, Inc.? Investors are caught in a whirlwind as a class action lawsuit reveals some murky details that many didn't see coming. Grab a chair, 'cause we're diving deep into what this could mean for you and your portfolio. What's This Legal Drama About? The lawsuit slaps Arbor Realty with...

U-wifi Gains Charlie Vogt: Key Steps in 5G Expansion

Charlie Vogt Joins U-wifi: A Broadband Game Changer? There's a new player in town shaking things up, and he's no rookie. Charlie Vogt, five-time technology CEO and Managing Director at Bowen, is hopping onto U-wifi's board of directors. This isn't just about another corporate announcement; it's like adding a veteran quarterback to your expansion team. Vogt’s pedigree in...

BlackRock's New Twist on Pension-Like 401(k) Benefits

Rethinking Retirement: BlackRock's Pension-Style 401(k) Plans Everyone and their grandma knows the traditional pension is on life support in America's workforce. BlackRock's latest moves might just be that little jolt the market needs to reinject a bit of certainty for retirees. Nick Nefouse, steering the ship at BlackRock's Retirement Solutions, hopped on the Retirement...

Lululemon Lawsuit Looms: Investors Face Key Decisions

Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...

Celebrating Ted Turner's Legacy at the United Nations

Ted Turner's Unyielding Vision Celebrated at UN Gala Here we are, talking about Ted Turner, a guy who truly put his money where his mouth was. Not just another rich cat content with the status quo, he dropped a $1 billion bombshell in 1997 on the United Nations to shake up how the world's problems could be tackled. And last week, on November 9, notable bigwigs of the...